<div>GA: gestational age; gw: gestational week *: number of samples analysed
for anti-D
concentration per woman</div><div>Legends</div><div>Figure 1. Anti-D concentration (IU/L) at inclusion in the study at week
38±1, n=39, after administration of RAADP 1500 IU in gestational week
28. The dotted line represents LOD for detection of Anti-D with
type-and-screen, 10 IU/L (2 µg/L), with 17/39 below LOD.</div><div>Figure 2. Increase of anti-D IgG after administration of RAADP 1500 IU
in pregnancy week 38 was quantified by flow cytometry one week after
administration. Linear regression analysis showed a significant
correlation to body mass index, p=0.0118, n=39.</div><div>Figure 3.</div><div>Concentrations of anti-D measured by flow cytometry at different time
points after delivery. Data are shown as box plots with median values
and quartiles in the box and the range as whiskers. n = no of anti-D
analyses performed at delivery and each week after delivery.</div>